Genetic instrument evidence for causal LDL effect
The argument
Because linked claim, there is a genetic association to interpret; and because linked claim, that association can be read causally rather than as confounded correlation, since genotype is fixed at conception and precedes disease. The convergence of linked claim with the genetic estimates provides independent corroboration of the causal reading.
Does it work?
Not yet evaluated.
Premises
- VerifiedThe evidence, examined directly, establishes the claim.constitution →Genetic variants that lower LDL cholesterol are associated with proportionally lower cardiovascular disease risk
- SupportedThe evidence favors the claim, but the examination is incomplete or the evidence is indirect.constitution →Genetic instruments for LDL cholesterol affect cardiovascular risk only through LDL and not through confounding pleiotropy
- VerifiedThe evidence, examined directly, establishes the claim.constitution →Randomized trials show lowering LDL cholesterol reduces cardiovascular events proportionally to the reduction achieved
Where it is made
Passages where sources make, criticize or mention this argument. They record where it appears, not how strong it is, and none has precedence over another.
No source is recorded as making it.
Earlier ratings
- Jul 28, 2026
The inference goes through: a fixed-at-conception genetic association read under the no-pleiotropy assumption licenses a causal reading, and the trial convergence corroborates it. It stands on the proportional genetic dose-response, now verified, and on the assumption that the instruments act only through LDL, which is the load-bearing premise and is supported rather than settled. That assumption carries the argument's residual weight; the cross-gene concordance and the convergence with randomized LDL-lowering trials are what make it hold in this case rather than merely be assumed.